← Back to Search

PhysZou emPOWER for Cerebral Palsy

N/A
Waitlist Available
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before pt intervention begins (week 1), midpoint of program (week 7), and last week of program (week 15).
Awards & highlights

Summary

The purpose of the Mizzou emPOWER program is to meet the curricular needs of entry-level doctorate of physical therapy students by providing them the real-world experience of implementing recent evidence surrounding physical therapy dosing for children with cerebral palsy (CP) for power, strength, and gait interventions while meeting an unmet community need.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before pt intervention begins (week 1), midpoint of program (week 7), and last week of program (week 15).
This trial's timeline: 3 weeks for screening, Varies for treatment, and before pt intervention begins (week 1), midpoint of program (week 7), and last week of program (week 15). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
1 Repetition Maximum (1-RM) Testing
10 meter walk test
30 second half kneel to stand
+13 more
Secondary study objectives
Perspectives of Doctor of Physical Therapy Students
Perspectives of children and caregivers

Trial Design

1Treatment groups
Experimental Treatment
Group I: PhysZou emPOWERExperimental Treatment1 Intervention
Strength, power, and gait-based intervention for kids with cerebral palsy is embedded within a curricular pro-bono student physical therapy clinic. The group will meet for 2 hours, 2 times per week for 15 weeks.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
376 Previous Clinical Trials
628,680 Total Patients Enrolled
~4 spots leftby Dec 2024